GSK Backs Relation’s Cellular Data Engine

Company Relation Therapeutics / GSK Event Type Expanded Strategic Research Collaboration (Upfront and Milestone Payments) Modality Time-resolved human cellular perturbation data paired with an AI foundation model (MORGAN) Asset MORGAN cellular-biology foundation model; no named therapeutic asset Target Undisclosed; disease-mechanism and target discovery across unnamed…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *